← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Sciogen, Llc
San Jose, CA
$5,327,712
Total funding
3
Grants
Funding over time
peak $999.3K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,327,712 · 3
By mechanism
R44$4,729,473 · 2
R43$598,239 · 1
Investigators at Sciogen, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Novel G protein-based RSV vaccine$999,290
R44 · FY2023 · AI
Novel G protein-based RSV vaccine$996,326
R44 · FY2024 · AI
Novel G protein-based RSV vaccine$972,321
R44 · FY2025 · AI
Development of a novel quadrivalent seasonal influenza vaccine using E.coli production technology$737,500
R44 · FY2016 · AI
Development of a novel quadrivalent seasonal influenza vaccine using E.coli production technology$722,269
R44 · FY2017 · AI
Development of a novel quadrivalent seasonal influenza vaccine using E.coli production technology$301,767
R44 · FY2018 · AI
Optimization of G Protein-based RSV Vaccines$299,501
R43 · FY2020 · AI
Optimization of G Protein-based RSV Vaccines$298,738
R43 · FY2021 · AI